spironolactone,placebo
Sponsors
Burapha University, Navamindrahiraj University Research Fund
Conditions
end stage renal disease patients on CAPD
CAPD
Hypokalemia
spironolactone
serum potassiumvascular calcification, peritoneal dialysis
coronary artery calcium score, peritoneal dialysis, vascular calcification, spironolactone
Phase 3
Effects of spironolactone in hypokalemic CAPD patients
Active, not recruitingTCTR20130314001
Start: 2013-03-20Target: 20Updated: 2026-08-03
Spironolactone to Prevent Progression of Vascular Calcification in Peritoneal Dialysis Patients
Active, not recruitingTCTR20221207001
Start: 2019-05-01Target: 60Updated: 2026-08-03